ORALE CANNABINOIDTABLETTE

European patent · EP3920890 · In force

Register entry

Publication number
EP3920890
Application number
EP20726699
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 17, 2020
Published
Dec 15, 2021
Granted
Nov 1, 2023
Protection ends at the latest
Apr 16, 2040
Next annual fee due
Apr 30, 2027
IPC classes
A61K 9/20 (2006.01)
A61K 9/24 (2006.01)
A61K 31/05 (2006.01)
A61K 31/352 (2006.01)
Priority
CA 3040513 17.04.2019
US 201916386477 17.04.2019
PCT application
PCT/DK2020/050100 17.04.2020
PCT publication
WO2020/211913 22.10.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. Sep 11, 2024

    Change

    Published in Swissreg on 11.09.2024

  4. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  5. Nov 20, 2023

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 20.11.2023

  6. Nov 1, 2023

    Granted

    Published in Swissreg on 01.11.2023

Parties

Holder

NordicCan A/S

Dandyvej 19, 7100 Vejle, DK

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

ERIKSEN, Ane

7100 Vejle, DK

BRUUN, Heidi Ziegler

7100 Vejle, DK

WITTORFF, Helle

7100 Vejle, DK

BOESEN, Dorte Schackinger

7100 Vejle, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.